Protara Therapeutics, Inc.

TARA
$4.08 (- $0.03 - 0.61%)
Last updated: 2026-07-09 17:12 UTC
TARA Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS74365U1079
CUSIP74365U107
Market Price4.08
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.39
Market Cap$294.2M
Book Value3.43
Price to Book1.602
Beta1.38
52w High7.82
52w Low2.77
Next Earnings DateN/A

Protara Therapeutics, Inc. trades under ticker TARA on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US74365U1079, CUSIP 74365U107.

About the Company
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Price History